Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Rakovina Therapeutics Inc., a biopharmaceutical company, is set to host an informational webinar on April 3, 2024, to discuss its collaboration with the Deep Docking AI platform and provide industry insights. Concurrently, the company has announced a new partnership with Insight Capital Partners Inc. to receive capital market advisory services, which includes automated market making services to aid in financial initiatives. The agreement with ICP entails a monthly fee and is initially set for a three-month term, with the potential for future extension and securities interest.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
